FDA Grants Priority Review to Pfizer's COVID-19 Vaccine

On July 16, the U.S. Food and Drug Administration (FDA) announced that the Pfizer/BioNTech COVID-19 vaccine has been granted priority review for full approval.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting